Financials data is unavailable for this security.
View more
Year on year Nanjing Well Pharmaceutical Group Co Ltd grew revenues 12.19% from 1.16bn to 1.30bn while net income improved 30.50% from 112.20m to 146.42m.
| Gross margin | 29.61% |
|---|---|
| Net profit margin | 11.10% |
| Operating margin | 13.49% |
| Return on assets | 6.00% |
|---|---|
| Return on equity | 8.61% |
| Return on investment | 8.02% |
More ▼
Cash flow in CNYView more
In 2024, Nanjing Well Pharmaceutical Group Co Ltd increased its cash reserves by 56.91%, or 89.65m. The company earned 221.79m from its operations for a Cash Flow Margin of 17.10%. In addition the company used 70.48m on investing activities and also paid 63.03m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 12.99 |
|---|---|
| Tangible book value per share | 12.18 |
More ▼
Balance sheet in CNYView more
| Current ratio | 1.29 |
|---|---|
| Quick ratio | 0.988 |
| Total debt/total equity | 0.3475 |
|---|---|
| Total debt/total capital | 0.2571 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 33.33% and 30.12%, respectively. The positive trend in dividend payments is noteworthy since only some companies in the Oil & Gas - Integrated industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.17% |
|---|---|
| Div growth rate (5 year) | 4.47% |
| Payout ratio (TTM) | 36.71% |
| EPS growth(5 years) | 1.70 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -2.49 |
More ▼
